Guidance

Carbapenemase-producing Gram-negative bacteria enhanced surveillance: ERS data collection manual

Describes the core and enhanced datasets in the electronic reporting system (ERS) for the enhanced surveillance of carbapenemase-producing Gram-negative bacteria.

• From: Public Health England
• Published: 30 April 2015
• Last updated: 12 July 2016 — See all updates

This publication was withdrawn on 24 April 2019

The Electronic Reporting System (ERS) enhanced surveillance website closed in April 2019. See AMRHAI reference unit: reference and diagnostic services for the latest guidance.

Documents

[Withdrawn] Electronic reporting system enhanced surveillance of carbapenemase-producing Gram-negative bacteria: data collection manual

Ref: PHE publications gateway number 2016141

PDF, 1.17 MB, 56 pages

View online

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The ERS serves 2 main functions as a system for:

• laboratories to request full characterisation of Gram-negative bacteria where expression of an acquired carbapenemase is suspected
• NHS Trusts to submit enhanced surveillance data

This guidance describes the 3 surveillance sections requiring data entry in the ERS:

• core dataset
• enhanced dataset: all patients
• enhanced dataset: admitted patients

Published 30 April 2015
Last updated 12 July 2016 + show all updates

1. 12 July 2016

   Updated to reflect changes following a system upgrade on 11 July 2016.

2. 30 April 2015

   First published.